StratDeck

Two stocks in Healthcare

Fresenius SE & Co. KGaA vs Gerresheimer: profit, growth, debt and price compared

Fresenius SE & Co. KGaA is stronger on 5 of 6 figures: profit margin, sales growth, debt, analysts' view and price trend. Gerresheimer is stronger on 1: price for its expected profit.

Figures as of 18 November 2026Yahoo Finance
Explore Fresenius SE & Co. KGaA's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Fresenius SE & Co. KGaA and Gerresheimer side by side
Fresenius SE & Co. KGaAFRE.DEGerresheimerGXI.DE
Net marginStronger: 6.6%−17.5%
Revenue growth, past yearStronger: +5.90%−0.80%
Debt to equityStronger: 57.0%236.7%
Forward P/E13.7×Stronger: 13.5×
Dividend yield1.95%—
AnalystsStronger: Strong buy · 14Hold · 12
From its 200-day averageStronger: +19.2%+13.7%

Share price over the past year

  • Fresenius SE & Co. KGaA+14.2%
  • Gerresheimer+40.9%

20 Nov 202518 Nov 2026

Fresenius SE & Co. KGaA or Gerresheimer: which is stronger?

  • FRE.DE

    Which is more profitable?

    Fresenius SE & Co. KGaA keeps more of each sale as profit: 6.6% against −17.5%.

  • FRE.DE

    Which is growing its sales faster?

    Fresenius SE & Co. KGaA is growing its sales faster: +5.90% over the past year, against −0.80%.

  • FRE.DE

    Which has borrowed less?

    Fresenius SE & Co. KGaA has borrowed less: its debt is 57.0% of what its shareholders own, against 236.7% for Gerresheimer.

  • GXI.DE

    Which costs less for the profit it is expected to make?

    Gerresheimer costs less for the profit it is expected to make: 13.5× its forward earnings, against 13.7×.

  • FRE.DE

    Which do analysts rate higher?

    Analysts are warmer on Fresenius SE & Co. KGaA: Strong buy, against Hold for Gerresheimer.

  • FRE.DE

    Which is in the stronger price trend?

    Fresenius SE & Co. KGaA's price is in the stronger trend: 19.2% above its 200-day average, against 13.7% above.

What each company does

FRE.DEFresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa.

Reports results on 24 February 2027

GXI.DEGerresheimer

Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally.

Reports results on 25 November 2026

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every European healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.